Curve Biosciences
PrivateLast Round
Series A
Oct 29, 2025
Est. Valuation
$32.7M
Total Funding Raised
$57.7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Curve Biosciences is a biotechnology company that develops AI-powered blood diagnostics and Whole-Body Blood Tests to monitor organ health and chronic disease progression.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Curve Biosciences Comparables
Compare Curve Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Predicine | 84% | |
| Singlera Genomics Inc. | 81% | |
| Helio Genomics | 80% | |
Curve Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 29, 2025 | ||||
| Seed | May 13, 2024 |
Key People
Founding team and executive leadership
Curve Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LifeX Ventures | Series A |
| NZVC | Seed, Series A |
| LifeX Ventures | Series A |
| LUMA Partners | Series A |
| First Spark Ventures | Seed, Series A |
| Incite Ventures | Seed, Series A |
| Techas Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 300% MoM, reaching 1.6K.
- May 13, 2026
Monthly visitors increased 162% MoM.
Curve Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Curve Biosciences's valuation, stock price, and market status.